Abstract:Microglia regulate immune responses in the brain, and their activation is key to the pathogenesis of diverse neurological diseases. Receptor-mediated lysophosphatidic acid (LPA) signaling has been known to regulate microglial biology, but it is still unclear which receptor subtypes guide the biology, particularly, microglial activation. Here, we investigated the pathogenic aspects of LPA receptor subtype 1 (LPA1) in microglial activation using a systemic lipopolysaccharide (LPS) administration-induced septic mouse model in vivo and LPS-stimulated rat primary microglia in vitro. LPA1 knockdown in the brain with its specific shRNA lentivirus attenuated the sepsis-induced microglia activation, morphological transformation, and proliferation. LPA1 knockdown also resulted in the downregulation of TNF-α, at both mRNA and protein levels in septic brains, but not IL-1β or IL-6. In rat primary microglia, genetic or pharmacological blockade of LPA1 attenuated gene upregulation and secretion of TNF-α in LPS-stimulated cells. In particular, the latter was associated with the suppressed TNF-α converting enzyme (TACE) activity. We reaffirmed these biological aspects using a BV2 microglial cell line in which LPA1 expression was negligible. LPA1 overexpression in BV2 cells led to significant increments in TNF-α production upon stimulation with LPS, whereas inhibiting LPA1 reversed the production. We further identified ERK1/2, but not p38 MAPK or Akt, as the underlying effector pathway after LPA1 activation in both septic brains and stimulated microglia. The current findings of the novel role of LPA1 in microglial activation along with its mechanistic aspects could be applied to understanding the pathogenesis of diverse neurological diseases that involve microglial activation.

Effect of lysophosphatidic acid on the expression of Toll-like receptor 4 of microglia in rats

Injection of lysophosphatidic acid into hippocampus induces hyperphosphorylation of tau protein and apoptosis in rats

Iysophosphatidic acid stimulates the activity of mouse primary microglia

Effect of lysophosphatidic acid on the expression of uPA and blood-brain barrier permeability

Effect of lysophosphatldic aeid on blood-brain barrier permeability and its mechanism

Involvement of lysophosphatidic acid in phosphorylation of phospho-Rb and apoptosis in rat hippocampal neurons

Effects of Lysophosphatidic Acid Receptor 5 on NLRC4 Inflammasome in Brain Tissues of Transient Cerebral Ischemia/reperfusion Rat.

Study of lysophosphatidic acid induces hippocampus astrocyte proliferation in vivo

Effect of lipoxin A4 on inflammatory response in a rat model of permanent focal cerebral ischemia

Effects of Lipoxin A4 on Inflammatory Response to Focal Cerebral Ischemia-Reperfusion Injury in Rats

Cerebral Ischemia-Reperfusion Injury: Lysophosphatidic Acid Mediates Inflammation by Decreasing the Expression of Liver X Receptor

Expression of Toll-like receptor 4 induced by extravasated IgG and peripheral LPS in rat brains

Preventive and Therapeutic Effects of Suramin on Lipopolysaccharide-Induced Mouse Model of Acute Lung Injury and Its Molecular Mechanism

Effect of Intracerebroventricular Injection of LPS on tau Hyperphosphorylation in Rat Hippocampus

Lysophosphatidic acid induced apoptosis in primary cultures of rat microglia cells

The Effects of NF-κB on Parkinson Disease Rat Model Induced by LPS

Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway

TLR4 signaling pathway mediates the LPS/ischemia-induced expression of monocytechemotactic protein-induced protein 1 in microglia

Identifying lysophosphatidic acid receptor subtype 1 (LPA1) as a novel factor to modulate microglial activation and their TNF-α production by activating ERK1/2

Effects of Toll-like receptor 4 in lipopolysaccharide induced acute lung injury

Lipoxin A4 Reduces Inflammation Through Formyl Peptide Receptor 2/p38 MAPK Signaling Pathway in Subarachnoid Hemorrhage Rats